Anthropic
Topic archive • 25 matches
AI-generated: summaries written by AI from the linked sources. How we use AI
2026-10-26
Technology
Anthropic has filed its S-1 with the SEC for a proposed initial public offering. The filing reveals that the company is increasingly reliant on natural gas to power its data centers, a dependency that is drawing scrutiny as it prepares to go public.
Business • Anthropic News
Permalink
Investment
ANT
Anthropic has officially filed its S-1 prospectus with the SEC for an IPO, planning to list on the Nasdaq under the ticker symbol 'ANT'. The filing reveals record revenue of $11.6 billion in the latest quarter and plans to raise billions, with an unusual governance structure to preserve founder control.
Permalink
2026-10-27
Technology
Anthropic says its scientists have engaged in deep research partnerships with six organizations developing new medicines, describing the work as early progress in a major effort to speed up drug development with Claude.
Research • Anthropic News
PermalinkBased on a transcript excerpt: Matthew Berman analyzes Anthropic's S-1 filing for its IPO, highlighting the company's stated belief that there is a greater than 10% chance AI kills all of humanity while also revealing its business model and growth dynamics. He discusses the apparent paradox of a safety-focused company going public and the self-reinforcing loops driving its adoption and investment.
AI Industry & Business • Matthew Berman
PermalinkA federal judge ruled in a May 2026 lawsuit that Anthropic illegally scraped and pirated the work of over 10 Stanford professors to train its Claude models. In Bartz v. Anthropic, Judge William Alsup ruled on the case, which the Authors Alliance calls the largest copyright settlement involving an AI company.
Legal • Hacker News
Permalink
Investment
ANTH
Anthropic's S-1 filing shows an 85% gross margin in H1 from running its models, a reality check for skeptics who said pay-as-you-go model sales wouldn't be profitable. The company also used its IPO letter to renew a pledge that Claude will never show ads.
Permalink
Tips
Productivity
Anthropic says that by default it will not use inputs or outputs from commercial products (e.g. Claude for Work, Anthropic API, Claude Gov) to train its models, but may use chats and coding sessions if you explicitly report feedback or bugs or otherwise allow it.
Permalink
2026-10-28
Technology
Based on a transcript excerpt: Fireship breaks down three weeks of AI market turmoil, explaining the circular financing arrangements behind GPU purchases and analyzing Anthropic's S-1 filing. Viewers learn how Nvidia's investments, GPU-backed borrowing, and Neo clouds create interconnected financial risk in the AI sector.
AI Industry & Finance • Fireship
PermalinkCybersecurity startup Cathedral used AI agents to breach Anthropic's internal systems through third-party software as part of a bug bounty program. Anthropic confirmed access to sales, HR, and IT data but disputes how deep the breach went, highlighting exposure through external software dependencies.
AI Safety • The Decoder
PermalinkGoogle opened Android Studio to third-party AI agents via a 'Bring Your Own Agent' feature supporting more than 40 coding agents, including Anthropic's Claude Agent and OpenAI's Codex. Google says new terminal tools help agents finish UI tasks 77% faster while using up to three times fewer tokens.
Developer Tools • The Decoder
PermalinkAnthropic launched tools that show companies how their spending on its models is being used, lifting the curtain on usage ahead of a planned IPO. The move gives enterprise customers visibility into what their AI budgets are buying.
Business • TechCrunch AI
Permalink
Investment
AMZN
VCs are set to make billions on Anthropic's IPO, but Amazon is positioned to make much more, according to TechCrunch. Massive note conversions reveal the true extent of Amazon's ownership in Anthropic.
Permalink
Tips
Productivity
Mithril Medicine had one full-time employee supported by outside specialists and laboratories; its acquisition by Anthropic is described as a case study in how Claude can help coordinate drug research, with clinical progress still to be tested.
Permalink